Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, AIM ImmunoTech Inc (AMEX: AIM) closed at $0.20 down -3.78% from its previous closing price of $0.21. In other words, the price has decreased by -$3.78 from its previous closing price. On the day, 0.52 million shares were traded. AIM stock price reached its highest trading level at $0.2175 during the session, while it also had its lowest trading level at $0.19.
Ratios:
For a deeper understanding of AIM ImmunoTech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 21 ’24 when Equels Thomas K bought 20,000 shares for $0.21 per share. The transaction valued at 4,240 led to the insider holds 1,657,968 shares of the business.
MITCHELL WILLIAM M sold 4,580 shares of AIM for $884 on Dec 19 ’24. The Director now owns 118,549 shares after completing the transaction at $0.19 per share. On Dec 18 ’24, another insider, Equels Thomas K, who serves as the CEO & President of the company, bought 22,727 shares for $0.21 each. As a result, the insider paid 4,682 and bolstered with 1,680,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 12832395 and an Enterprise Value of 6039479. For the stock, the TTM Price-to-Sale (P/S) ratio is 71.66 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 30.047 whereas that against EBITDA is -0.193.
Stock Price History:
The Beta on a monthly basis for AIM is -0.29, which has changed by -0.52380955 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, AIM has reached a high of $0.62, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -5.32%, while the 200-Day Moving Average is calculated to be -35.85%.
Shares Statistics:
For the past three months, AIM has traded an average of 636.80K shares per day and 898630 over the past ten days. A total of 67.67M shares are outstanding, with a floating share count of 59.62M. Insiders hold about 11.89% of the company’s shares, while institutions hold 13.35% stake in the company. Shares short for AIM as of 1730332800 were 491374 with a Short Ratio of 0.99, compared to 1727654400 on 590329. Therefore, it implies a Short% of Shares Outstanding of 491374 and a Short% of Float of 0.8500000000000001.
